Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
13.68
+0.12 (0.88%)
Apr 30, 2025, 3:04 PM CST
SHE:300519 Revenue
Zhejiang Xinguang Pharmaceutical had revenue of 93.25M CNY in the quarter ending March 31, 2025, a decrease of -7.26%. This brings the company's revenue in the last twelve months to 260.36M, down -6.56% year-over-year. In the year 2024, Zhejiang Xinguang Pharmaceutical had annual revenue of 267.66M, down -1.01%.
Revenue (ttm)
260.36M
Revenue Growth
-6.56%
P/S Ratio
8.41
Revenue / Employee
826.55K
Employees
315
Market Cap
2.19B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 267.66M | -2.74M | -1.01% |
Dec 31, 2023 | 270.40M | -81.09M | -23.07% |
Jan 1, 2023 | 351.49M | 30.61M | 9.54% |
Jan 1, 2022 | 320.88M | 37.80M | 13.35% |
Dec 31, 2020 | 283.08M | -8.18M | -2.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |